Patient


 

Recently, Merck executive board member and CEO of Merck Healthcare Belén Garijo sat down with McKinsey’s Georg Nederegger to discuss what’s next for the pharma industry.

McKinsey: Looking ahead, where do you see the biggest growth opportunities for the pharma industry in general and Merck in particular?

Belén Garijo growth healthcare industry innovation market mckinsey Merck oncology patient

 

Avoiding Traumatic ESOP 1042 Election Distress [0.07]

Posted on Aug. 1, 2017, 3:15 p.m. by Alpha Architect @ [source]

Medical scientists have identified a disorder, known as Traumatic 1042 Election Distress, that can afflict business owners who pursue Section 1042 sales of their company stock to an ESOP. The disorder is curable if diagnosed early.

alpha bonds business owner disorder distress election money patient rollover Traumatic

 

The CEO of Shire explains how he’s repositioning the company and gearing up for more change. McKinsey senior partners Martin Dewhurst and Andy West recently talked with Shire’s CEO, Flemming Ørnskov, about the company’s efforts to transform and the importance of staying three steps ahead of the organization you’re leading.

ceo Flemming Ørnskov leading mckinsey organization patient product rare disease Shire team

 

A Verily Life Sciences executive explains how the company targets better patient outcomes by harnessing analytics, machine learning, and other digital tools. In this interview, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving, Jared Josleyn, global head of corporate development at Alphabet-owned Verily Life Sciences, talks with McKinsey’s Michele Raviscioni about the need to integrate health data and apply it to patients’ lives in ways that achieve enduring impact.

data disease healthcare improve Jared Josleyn outcome patient system tool Verily

 

Succeeding in emerging markets has been a challenging undertaking for multinational pharma companies, but those that adapt their end-to-end model for emerging markets could well thrive.

A few years ago, multinational pharma companies seeking growth and respite from market uncertainty in Europe and the United States found a haven in emerging markets.

access adapt companies countries emerging market growth local market multinational patient

 

Amid the country’s downturn, should companies still be looking here for growth?

Five years ago, Nigeria’s strong economic growth sparked a burst of enthusiasm about opportunities in its pharmaceutical market.

companies drug economic growth healthcare local Nigeria patient pharma Pocket

 

A Tidal Wave is Coming [0.05]

Posted on April 24, 2017, 1:58 p.m. by The Irrelevant Investor @ [source]

In light of the French election over the weekend and with global stocks up bigly, we’re no doubt in for a tidal wave of narratives connecting fundamentals to price. With his left hand the patient selected a picture of a shovel, and with his right hand, he selected a picture of a chicken.

asked brain chicken claw hemisphere left patient picture shovel snow

 

New models of healthcare [0.17]

Posted on April 5, 2017, 1:37 p.m. by McKinsey Insights & Publications @ [source]

Healthcare systems are struggling to meet the evolving needs of patients.

Healthcare systems globally face huge challenges in delivering high-quality, accessible, and affordable care, often to populations that are increasingly aging and have a growing prevalence of long-term conditions.

care children health hospital model patient primary rate services system

 

An executive partner at Flagship Pioneering discusses what’s next for the industry, disruptive technologies, and patient care.

What’s next for the pharmaceuticals industry, amid digital disruption and rapid technological advances?

address companies conversation doctor Epstein innovation patient pharmaceutical targeted therapy

 

Loading... Loading...

Big Data technology is having a lot more real world applications than we could have ever envisaged. Big Data has effects on the financial sector, economy, technology, and now perhaps even health.

big data data effects experts health human model patient provide valuable

 

The life-sciences industry is embracing digital to unlock innovation. We spoke to ten digital leaders at global pharmaceutical companies to understand how they focus their efforts.

analytics companies design focus insights patient pharmaceutical solutions team tool

 

Two executives from a digital diabetes-management start-up discuss the importance of a patient focus and ways innovation is shaping the industry. Companion apps also offer a way to collect vast quantities of real-world patient data that can be used as appropriate to improve treatment protocols and drug development.

Anton apps data diabetes focused HbA1c health healthcare outcomes patient

 

Book Bits |14 January 2017 [0.11]

Posted on Jan. 14, 2017, 12:08 p.m. by The Capital Spectator @ [source]

By Martin Stuchtey, et al.

Companies that have nothing to do with our medical treatment are allowed to buy and sell our health care data, provided they remove certain fields of information, including birth date, name and Social Security number.

argues Auslin business data disruption economies economism patient region war

 

While all drug launches are complex, launches of rare disease treatments are particularly so. Our experience suggests that companies that launch rare disease treatments must excel in four areas.

area companies disease drug launch orphan patient rare disease small treatment

 

Loading... Loading...

Healthcare apps in Asia are still building up momentum. However, there are some apps that just stand out.

apps blood data doctor location makes patient Scoliosis stroke user

 

A Danish pharma company’s strong customer focus and determined digital drive have important lessons for other businesses. McKinsey senior partner Martin Møller recently talked with LEO Pharma’s president and CEO, Gitte Aabo, about the group’s efforts to better understand the needs of patients and about its recent investment in LEO Innovation Lab, a stand-alone unit designed to develop digital solutions for patients.

develop environment LEO patient pharma senior start up treatment unit year

 

A Danish pharma company’s strong customer focus and determined digital drive have important lessons for other businesses. McKinsey senior partner Martin Møller recently talked with LEO Pharma’s president and CEO, Gitte Aabo, about the group’s efforts to better understand the needs of patients and about its recent investment in LEO Innovation Lab, a stand-alone unit designed to develop digital solutions for patients.

develop environment LEO patient pharma senior start up treatment unit year

 

Loading... Loading...

With all of the amazing prospects that the technology world has witnessed in the development of the internet of things, one question that continues to be asked is whether we can expect to see this innovation in healthcare in the near future. Technology always brings a way for humans to advance and evolve past the problems that we experience in a particular age, so one thing that learned minds wonder about, is whether the internet of things will bring new solutions to the healthcare sector.

bring data devices healthcare internet machine patient possibility system things

 

Closing the digital gap in pharma [0.06]

Posted on Nov. 23, 2016, 3:47 p.m. by McKinsey Insights & Publications @ [source]

New research on the digital maturity of pharma, relative to other industries, reveals clear opportunities to improve performance by better connecting digitally with patients and physicians.

Digital is transforming the way the world does business, and healthcare is no exception.

assessment companies healthcare journey leaders patient pharma pharma companies provider strategy

 

Loading... Loading...

In recent times, there has been a lot of interest developing in the potentials of Blockchain technology. This subject has been the rave of a lot of tech blogs.

blockchain data enhance feel financial healthcare Infact innovation patient potential recent times